Functionalized benzoxazole derivatives were designed and synthesized based on the structural features of PIB and FDDNP, which show excellent binding affinities to aggregated Aβ42 fibrils. All the synthesized compounds were evaluated by competitive binding assay against aggregated Aβ42 fibrils using [ 
Introduction
Alzheimer's disease (AD) is a neurodegenerative disease characterized by a slow and progressive decline in cognitive function and behavior. 1, 2 The two characteristic neuropathological features in AD are senile plaques (SPs) composed of aggregates of amyloid β (Aβ) peptides and intracellular neurofibrillary tangles (NFTs) in the brain. 3, 4 The accumulation of Aβ and formation of plaques correlates with the severity of dementia. A regulated cascade of the proteolytic cleavage of β-amyloid precursor protein (β-APP) generates Aβ40 and Aβ42. 5, 6 Of two most abundant forms of Aβ, Aβ42 as a toxic species of Aβ has been shown to aggregate into amyloid fibrils more readily than Aβ40. [7] [8] [9] Accordingly, extracellular deposits of amyloid fibrils formed by Aβ42 become the attractive targets for drug intervention. [10] [11] [12] The Aβ fibrils binding agents may potentially be useful for early detection and monitoring the progression of AD. Currently, development of specific imaging agents available for direct mapping of Aβ aggregates in the living brain has been investigated. 13, 14 a neutral and highly lipophilic imaging agent, was developed for detection of both senile plaques and neurofibrillary tangles in the living brain of AD patients using positron emission tomography (PET). Recently, N-methyl-[ 15, 16 as an in vivo PET β-sheet imaging agent exhibited high affinity for Aβ, good brain entry and clearance. For early diagnosis or monitoring of β-amyloid formation and aggregation in AD brain, a variety of radiolabeled compounds as imaging probes have been developed. [17] [18] [19] The development of ligands specifically binding to β-amyloid aggregates is very important for labeling agents as in vivo diagnostic tools. Our continuous object has been to explore the novel ligands applicable to imaging probes with high binding affinity to Aβ fibrils. 20, 21 Based on the structural combination of PIB and FDDNP, functionalized benzoxazole derivatives capable of radioisotope labeling on terminal amine were designed as shown in Figure 1 . We report here the synthesis and evaluation of a series of benzoxazole derivatives with high affinities for Aβ42 fibrils.
Results and Discussion
Chemistry. Benzoxazole-6-carboxylate 1a, a key intermediate for further functionalization, was prepared by the sequence outlined in Scheme 1.
Esterification of carboxylic group of 2 with thionyl chloride in ethanol followed by ring closure of resulting ester 3 with 4-dimethylaminobenzoyl chloride in the presence of boric acid provided the compound 1a. 22, 23 The ethyl ester of 1a was reduced using lithium aluminum chloride in THF to give the hydroxyl compound 4, and then oxidized with pyridinium dichromate to afford the aldehyde 5. Weinreb amide coupling of 1a with N,O-dimethylhydroxylamine hydrochloride in the presence of triethylamine, 24 and subsequent alkylation with methylmagnesium iodide were carried out in usual manner to give the ketone 6. 25 Carboxylic acid 1b was obtained by the hydrolysis of ester 1a with potassium hydroxide. 26 Compounds 5 and 7 were served as intermediates for the synthesis of benzoxazoles 1c-f bearing olefin moieties (Scheme 2).
Knoevenagel condensation of compounds 5 and 7 with malonic acid in pyridine-piperidine gave the corresponding title compounds 1c and 1d. Compounds 1e and 1f were prepared by the treatment with malononitrile and triphenylphospine in pyridine.
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Biological Evaluation. Table 1 shows the in vitro binding affinities (K i values) of benzoxazole derivatives 1a-f against aggregated Aβ42 fibrils together with that of PIB as a reference compound.
All the synthesized compounds were evaluated by competitive binding assays against Aβ42 fibrils using [ Scheme 2. Reagent and reaction conditions: (i) malonic acid, pyridine, piperidine, reflux, 2-4 h, 32% (for 1c), 52% (for 1d); (ii) malononitrile, PPh3, pyridine, reflux, 6-18 h, 58% (for 1e), 37% (for 1f). 23 using Graphpad Prism soft-ware.
In conclusion, functionalized benzoxazole derivatives based on the structural features of PIB and FDDNP showed excellent binding affinities to aggregated Aβ42 fibrils. These compounds could be considered as ligands for molecular imaging agents to monitor Aβ42 fibrils in AD brain due to their high binding affinity.
Experimental
Melting points were measured with a Thomas Hoover capillary melting point apparatus and were uncorrected. IR spectra were obtained on a Perkin-Elmer FT-IR system spectrophotometer. C) using tetramethylsilane as an internal standard. GC-Mass spectra were determined on a Agilent Technology 6890N network GC system. Column chromatography was carried out using silica gel (230-400 mesh). Solvents and liquid reagents were transferred using hypodermic syringes. All other reagents and solvents used were reagent grade. 
2-4-(Dimethylaminophenyl-N-methoxy-N-methylbenzo-[d]oxazole-6-carboxamide (6).
To a solution of 5 (300 mg, 3.0 mmol) in CH 2 Cl 2 (15 mL) were added N,O-dimethylhydroxylamine hydrochloride (264 mg, 2.7 mmol) and Et 3 N (0.8 mL, 6.0 mmol), and the reaction mixture was stirred at room temperature for 5 h. When the reaction was completed, the reaction mixture was treated with 10% NaHCO 3 . The mixture was extracted with ethyl acetate, dried over anhydrous Na 2 SO 4 , and concentrated in vacuo. The residue was purified by silica gel column chromatography (n-hexane/ ethyl acetate = 3:1) to give 6 (255 mg, 87%): 
1-(2-(4-Dimethylaminophenyl)benzo[d]oxazol-6-yl)ethanone (7).
To a solution of 6 (83 mg, 0.25 mmol) in diethyl ether (2 mL) was added methylmagnesium iodide (10 mL, 0.28 mmol) at 0 o C, and the reaction mixture was stirred at room temperature for 3 h. When the reaction was completed, the reaction mixture was treated with 10% NaHCO 3 . The mixture was extracted with ethyl acetate, dried over anhydrous Na 2 SO 4 , and concentrated in vacuo. The residue was purified by silica gel column chromatography (n-hexane/ ethyl acetate = 3:1) to give 7 (26 mg, 37%): ]TZDM binding. The mixture was incubated at room temperature for 3 h and the bound and the free radioactivity were separated by a vacuum filtration through Whatman GF/ B filters using a Brandel M-24R cell harvester followed by 2·3 mL washes of 10% EtOH at room temperature. Filters containing the bound radioligand were counted in a gammacounter (Cobra-II). The result of inhibition assays was subjected to nonlinear regression analysis using software Graphpad Prism by K i values was calculated.
